| 1. |
Zhang XT, Zhong YF, Xue YQ, et al. Clinical features of central retinal vein occlusion in young patients[J]. Ophthalmol Ther, 2022, 11(4): 1409-1422. DOI: 10.1007/s40123-022-00534-7.
|
| 2. |
Chen TY, Uppuluri A, Zarbin MA, et al. Risk factors for central retinal vein occlusion in young adults[J]. Eur J Ophthalmol, 2021, 31(5): 2546-2555. DOI: 10.1177/1120672120960333.
|
| 3. |
Sinawat S, Bunyavee C, Ratanapakorn T, et al. Systemic abnormalities associated with retinal vein occlusion in young patients[J]. Clin Ophthalmol, 2017, 11: 441-447. DOI: 10.2147/OPTH.S128341.
|
| 4. |
Nalcaci S, Degirmenci C, Akkin C, et al. Etiological factors in young patients with retinal vein occlusion[J]. Pak J Med Sci, 2019, 35(5): 1397-1401. DOI: 10.12669/pjms.35.5.546.
|
| 5. |
Trentin F, Zucchi D, Signorini V, et al. One year in review 2021: systemic lupus erythematosus[J]. Clin Exp Rheumatol, 2021, 39(2): 231-241. DOI: 10.55563/clinexprheumatol/7gzsxp.
|
| 6. |
Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview[J]. Clin Exp Med, 2018, 18(2): 135-149. DOI: 10.1007/s10238-017-0479-9.
|
| 7. |
杜虹, 陸慧琴, 戴榮平. 系統性紅斑狼瘡眼底病變評估和分型[J]. 眼科新進展, 2017, 37(8): 766-769. DOI: 10.13389/j.cnki.rao.2017.0194.Du H, Lu HQ, Dai RP. Evaluation and types of fundus characters in systemic lupus erythematosus[J]. Rec Adv Ophthalmol, 2017, 37(8): 766-769. DOI: 10.13389/j.cnki.rao.2017.0194.
|
| 8. |
Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop[J]. Arthritis Rheum, 1999, 42(7): 1309-1311. DOI: 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F.
|
| 9. |
中華醫學會風濕病學分會. 抗磷脂綜合征診斷和治療指南[J]. 中華風濕病學雜志, 2011, 15(6): 407-410. DOI: 10.3760/cma.j.issn.1007-7480.2011.06.012.Rheumatology Branch of Chinese Medical Association. Guidelines for diagnosis and treatment of antiphospholipid syndrome[J]. Chin J Rheumatol, 2011, 15(6): 407-410. DOI: 10.3760/cma.j.issn.1007-7480.2011.06.012.
|
| 10. |
喬鵬燕, 張莉蕓. 系統性紅斑狼瘡繼發抗磷脂綜合征[J]. 中國實用內科雜志, 2021, 41(9): 745-748. DOI: 10.19538/j.nk2021090103.Qiao PY, Zhang LY. Systemic lupus erythematosus with secondary antiphospholipid syndrome[J]. Chin J Pract Inter Med, 2021, 41(9): 745-748. DOI: 10.19538/j.nk2021090103.
|
| 11. |
劉暢, 趙金霞. 抗磷脂綜合征相關血管病變的診治進展[J]. 中華風濕病學雜志, 2021, 25(4): 277-282. DOI: 10.3760/cma.j.c141217-20200106-00005.Liu C, Zhao JX. Progress in diagnosis and treatment of antiphospholipid syndrome-related vascular diseases[J]. Chin J Rheumatol, 2021, 25(4): 277-282. DOI: 10.3760/cma.j.c141217-20200106-00005.
|
| 12. |
黃媛, 崔巍. 抗磷脂綜合征血栓形成機制的研究進展[J]. 中華醫學雜志, 2016, 96(39): 3186-3189. DOI: 10.3760/cma.j.issn.0376-2491.2016.39.016.Huang Y, Cui W. Research progress on thrombosis mechanism of antiphospholipid syndrome[J]. Natl Med J China, 2016, 96(39): 3186-3189. DOI: 10.3760/cma.j.issn.0376-2491.2016.39.016.
|
| 13. |
王新陽, 楊濤. 抗磷脂抗體綜合征相關血栓病理機制的研究進展[J]. 中國血管外科雜志(電子版), 2023, 15(3): 279-283. DOI: 10.3969/j.issn.1674-7429.2023.03.019.Wang XY, Yang T. Research progress on the pathologic mechanism of antiphospholipid antibody syndrome-related thrombus[J]. Chin J Vasc Surg (Electronic Version), 2023, 15(3): 279-283. DOI: 10.3969/j.issn.1674-7429.2023.03.019.
|
